Stella Pharma Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	2,797	3,206	2,052	2,710	3,276	1,251
Short-Term Investments	-	-	300	-	-	-
Cash & Short-Term Investments	2,797	3,206	2,352	2,710	3,276	1,251
Cash Growth	-25.45%	36.31%	-13.21%	-17.28%	161.87%	-37.67%
Accounts Receivable	623	714	76	59	16	55
Receivables	623	714	76	59	16	55
Inventory	1,251	1,230	1,116	940	773	392
Prepaid Expenses	76	49	40	39	36	40
Other Current Assets	27	44	45	44	74	72
Total Current Assets	4,774	5,243	3,629	3,792	4,175	1,810
Property, Plant & Equipment	55	66	81	102	92	68
Long-Term Investments	48	57	57	371	382	89
Other Intangible Assets	45	49	52	61	68	79
Other Long-Term Assets	2	2	1	3	1	2
Total Assets	4,924	5,417	3,820	4,329	4,718	2,048
Accounts Payable	60	22	75	49	48	62
Accrued Expenses	17	7	4	6	2	47
Current Portion of Long-Term Debt	158	158	160	160	160	160
Current Income Taxes Payable	43	197	212	202	92	45
Other Current Liabilities	9	6	4	4	6	5
Total Current Liabilities	287	390	455	421	308	319
Long-Term Debt	528	608	773	933	1,093	1,253
Pension & Post-Retirement Benefits	60	59	53	47	51	46
Other Long-Term Liabilities	1,150	1,153	163	176	187	200
Total Liabilities	2,025	2,210	1,444	1,577	1,639	1,818
Common Stock	2,859	2,859	2,938	3,300	3,808	1,999
Additional Paid-In Capital	348	489	195	220	1,908	99
Retained Earnings	-307	-140	-763	-778	-2,636	-1,869
Comprehensive Income & Other	-1	-1	6	10	-1	1
Shareholders' Equity	2,899	3,207	2,376	2,752	3,079	230
Total Liabilities & Equity	4,924	5,417	3,820	4,329	4,718	2,048
Total Debt	686	766	933	1,093	1,253	1,413
Net Cash (Debt)	2,111	2,440	1,419	1,617	2,023	-162
Net Cash Growth	-27.18%	71.95%	-12.25%	-20.07%	-	-
Net Cash Per Share	62.04	73.10	45.81	56.00	72.04	-8.09
Filing Date Shares Outstanding	34.02	34.02	31.22	29.48	28.65	20.14
Total Common Shares Outstanding	34.02	34.02	31.22	29.48	28.65	20.14
Working Capital	4,487	4,853	3,174	3,371	3,867	1,491
Book Value Per Share	85.20	94.27	76.10	93.35	107.48	11.42
Tangible Book Value	2,854	3,158	2,324	2,691	3,011	151
Tangible Book Value Per Share	83.88	92.83	74.43	91.28	105.10	7.50

Source: S&P Global Market Intelligence. Standard template. Financial Sources.